A61K 9/5068
Cell membranes or bacterial membranes enclosing drugs
Official title: {Cell membranes or bacterial membranes enclosing drugs (liposomes with additional exogenous lipids A61K9/127)}
A61K9/5068 (Cell membranes or bacterial membranes enclosing drugs) appears on 286 US grants and 682 published applications in this corpus.
Search patents in A61K- Granted patents
- 286
- Published applications
- 682
- Assignees
- 393
- Inventors
- 1,453
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 6 | 0 |
| 1995 | 2 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 2 |
| 2002 | 0 | 4 |
| 2003 | 4 | 9 |
| 2004 | 3 | 7 |
| 2005 | 5 | 5 |
| 2006 | 1 | 10 |
| 2007 | 1 | 6 |
| 2008 | 5 | 6 |
| 2009 | 3 | 6 |
| 2010 | 1 | 8 |
| 2011 | 3 | 10 |
| 2012 | 3 | 8 |
| 2013 | 8 | 16 |
| 2014 | 7 | 18 |
| 2015 | 8 | 14 |
| 2016 | 7 | 20 |
| 2017 | 9 | 18 |
| 2018 | 6 | 40 |
| 2019 | 22 | 38 |
| 2020 | 25 | 37 |
| 2021 | 17 | 50 |
| 2022 | 19 | 43 |
| 2023 | 14 | 57 |
| 2024 | 17 | 68 |
| 2025 | 25 | 98 |
| 2026 | 24 | 84 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fusion protein comprising anti-CD3 single domain antibody, exosomal protein CD63 and RNA binding protein, and uses thereof6 Oct 2026US 12,753,232 B1China Medical University Hospital
- Compositions and methods for wound healing29 Sep 2026US 12,746,278 B2The Regenents of the University of California
- Methods of loading extracellular vesicles29 Sep 2026US 12,746,291 B2Lonza Sales AG
- circCDK13-enriched engineered small extracellular vesicle (E-sEV), and preparation method and use thereof22 Sep 2026US 12,740,945 B2Chinese Pla General Hospital
- Engineered exosome for treating hypertrophic scar (HTS), and preparation method and use thereof15 Sep 2026US 12,735,708 B2Chinese Pla General Hospital
- Composition and Method for Topical Trans-spinal Delivery of Nucleic Acids and Small Molecules8 Oct 2026US 2026/0306414 A13P Biotechnologies, Inc.
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
- Extracellular vesicles for the delivery of payloads to eukaryotic cells8 Oct 2026US 2026/0306416 A1Alaya.bio Inc.
- Compositions and methodology for delivery of alpha-galactosylceramide compounds1 Oct 2026US 2026/0294822 A1EnGeneIC Molecular Delivery Pty Ltd
- Planet atmosphere gases enwrapped into composite nanomaterials with medical treatment applications1 Oct 2026US 2026/0294961 A1Arizona Board of Regents on Behalf of the University of Arizona
Most cited
By later US patents
- Glucan drug delivery system and adjuvant141US 5,607,677 AAlpha-Beta Technology, Inc. · 1997
- Glucan drug delivery system and adjuvant126US 5,032,401 AAlpha-Beta Technology, Inc. · 1991
- Apparatus and method for electroporation of biological samples114US 7,141,425 B2MaxCyte, Inc. · 2006
- Delivery of an agent103US 6,812,204 B1Gendel Limited · 2004
- Glucan drug delivery system and adjuvant90US 5,741,495 AAlpha-Beta Technology, Inc. · 1998